Sequenom, Inc. (NASDAQ:SQNM), a life sciences firm giving innovative genetic analysis solutions, on Thursday declared revenue of $38.5 million for the first quarter of this year, a hike of 158% in contrast to revenue of $14.9 million for the first quarter of 2012. First quarter 2013 revenues from the Sequenom Center for Molecular Medicine (Sequenom CMM) diagnostics services operating segment enhanced above 38% in contrast to the fourth quarter of last year.
Sequenom, Inc. (NASDAQ:SQNM) shares in the current session moved up +16.39% reaching at $4.16. The stock traded in a range of $4.00 – $4.22. In the last year the stock has moved within a range of $2.65 – $5.36. The current session’s volume of 5.93 million shares is higher from their average daily trading volume of 2.34million shares.
Assured Guaranty Ltd. (NYSE:AGO) (“AGL” and, together with its subsidiaries, “Assured Guaranty” or the “Company”) declared late on Thursday its financial earnings for the three-month phase concluded on March 31, 2013 (“first quarter 2013”). The Company declared operating income for first quarter this year of $260 million, or $1.34 per share.
Another rival company Assured Guaranty Ltd. (NYSE:AGO) trading up +0.55% to $23.80. Intraday trading recorded the stock price in a range of $23.48 to $24.24. In the previous 52 weeks the stock’s price ranged between $11.17 and $24.24. The current session’s volume of 2.17 million shares was higher from their average daily trading volume of 1.79 million shares.
DO NOT TRADE ANY STOCK WITHOUT LEVEL 2 STOCK QUOTES! QuoteDaddy.com delivers it's user with the most in-depth Level 2 Quotation System available on the Planet! NO Downloads, NO Widgets, NO Plugins required! Stay on TOP of your trades with QuoteDaddy.com! CLICK HERE TO START YOUR FREE 30-DAY TRIAL